Botox & Migraines

Botox (onabotulinumtoxinA) is a purified protein derived from the bacterium Clostridium botulinum. While best known for cosmetic use, it received FDA approval in 2010 specifically for chronic migraine prevention. Chronic migraine is defined as 15 or more headache days per month, with at least 8 of those being migraine days.

Botox works for migraines differently than it works for wrinkles. It blocks the release of certain neurotransmitters involved in pain transmission, particularly CGRP and substance P, from nerve endings near the injection sites. This reduces the sensitivity of pain pathways in the head and neck area, making it harder for migraine attacks to get started.

A Botox treatment session involves 31 injections across seven specific areas of the head and neck: the forehead, temples, back of the head, upper neck, and upper back/shoulders. Each injection delivers a small amount of Botox using a very fine needle. The entire procedure takes about 15-20 minutes and is performed in a doctor's office.

Treatments are given every 12 weeks (about every three months). Many people don't notice significant improvement after just one session. Two treatment cycles (about 24 weeks) are typically needed to judge effectiveness fairly. Some insurance plans require documentation of failure with two or more oral preventive medications before approving Botox.

The most common side effects are neck pain, headache (ironically), and injection site discomfort in the days following treatment. Some people experience temporary muscle weakness in the neck area. Drooping eyelids (ptosis) can occur if the medication migrates, but this is uncommon with an experienced injector and resolves on its own.

Botox for migraines should only be administered by a healthcare provider trained in the specific 31-injection protocol (called the PREEMPT protocol). The treatment is not recommended for people who have fewer than 15 headache days per month (episodic migraine), as clinical trials did not show benefit in that population. Each session costs significantly without insurance, making coverage documentation important.

The landmark PREEMPT trials demonstrated that Botox reduces headache days by an average of 8-9 days per month in people with chronic migraine. About 47% of participants achieved at least a 50% reduction in headache days. The benefit tends to increase with successive treatment cycles, so the third and fourth sessions often produce better results than the first.

Research also shows that Botox can reduce the use of acute medications, which is particularly important for people caught in a medication overuse cycle. For patients who have failed multiple oral preventives, Botox offers a different approach that doesn't require remembering a daily pill and avoids systemic side effects like weight changes or cognitive issues.

Because Botox sessions are 12 weeks apart, consistent tracking between sessions provides your doctor with the detailed picture needed to assess whether treatment is working and whether the injection pattern needs adjusting. Log every headache and migraine day in CalmGrid, along with severity and acute medication use.

Many people notice a pattern where Botox's effect peaks around weeks 4-8 and starts wearing off before the next session. Tracking this pattern helps your doctor understand your personal response timeline. If you're using CalmGrid data to support an insurance appeal for Botox coverage, detailed daily records of headache frequency and failed previous treatments can make a strong case.